Browse by People

Collapse authors list.
Darlow, Christopher ORCID: 0000-0002-5400-3413, Farrington, Nicola, McEntee, Laura, Johnson, Adam, Unsworth, Jennifer, Jimenez-Valverde, Ana ORCID: 0000-0003-4284-5629, Jagota, Bhavana, Docobo-Perez, Fernando, Kolamunnage-Dona, Ruwanthi ORCID: 0000-0003-3886-6208, de Costa, Renata et al (show 7 more authors) , Ellis, Sally, Franceschi, François, Sharland, Mike, Neely, Michael, Piddock, Laura, Das, Shampa and Hope, William (2022) 30 Determining a potential alternative empirical antibiotic regimen for the treatment of neonatal sepsis in low- and middle-income settings using pre-clinical in vitro techniques. Clinical Infection in Practice, 15. p. 100191.

Collapse authors list.
Darlow, Christopher A ORCID: 0000-0002-5400-3413, Docobo-Perez, Fernando, Farrington, Nicola, Johnson, Adam, McEntee, Laura, Unsworth, Jennifer, Jimenez-Valverde, Ana, Gastine, Silke, Dona, Ruwanthi Kolamunnage, de Costa, Renata MA et al (show 8 more authors) , Ellis, Sally, Franceschi, François, Standing, Joseph F, Sharland, Mike, Neely, Michael, Piddock, Laura, Das, Shampa ORCID: 0000-0002-2540-4816 and Hope, William ORCID: 0000-0001-6187-878X (2021) Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance. Antimicrobial Agents and Chemotherapy, 65 (7). e0029321-.

Collapse authors list.
Darlow, Christopher A ORCID: 0000-0002-5400-3413, McEntee, Laura, Johnson, Adam, Farrington, Nicola, Unsworth, Jennifer, Jimenez-Valverde, Ana ORCID: 0000-0003-4284-5629, Jagota, Bhavana, Kolamunnage-Dona, Ruwanthi ORCID: 0000-0003-3886-6208, Da Costa, Renata MA, Ellis, Sally et al (show 6 more authors) , Franceschi, Francois, Sharland, Mike, Neely, Michael, Piddock, Laura, Das, Shampa ORCID: 0000-0002-2540-4816 and Hope, William ORCID: 0000-0001-6187-878X (2022) Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77 (12). pp. 3349-3357.

Collapse authors list.
de Graaf, Hans, Sukhtankar, Priya, Arch, Barbara ORCID: 0000-0001-6060-8091, Ahmad, Nusreen, Lees, Amanda, Bennett, Abigail, Spowart, Catherine, Hickey, Helen ORCID: 0000-0003-0467-0362, Jeanes, Annmarie, Armon, Kate et al (show 18 more authors) , Riordan, Andrew, Herberg, Jethro, Hackett, Scott, Gamble, Carrol ORCID: 0000-0002-3021-1955, Shingadia, Delane, Pallett, Ann, Clarke, Stuart C, Henman, Philip, Emonts, Marieke, Sharland, Mike, Finn, Adam, Pollard, Andrew J, Powell, Colin, Marsh, Peter, Ballinger, Claire, Williamson, Paula R ORCID: 0000-0001-9802-6636, Clarke, Nicholas MP and Faust, Saul N (2017) Duration of intravenous antibiotic therapy for children with acute osteomyelitis or septic arthritis: a feasibility study. HEALTH TECHNOLOGY ASSESSMENT, 21 (48). 1-+.

Collapse authors list.
Bielicki, Julia A, Stohr, Wolfgang, Barratt, Sam, Dunn, David, Naufal, Nishdha, Roland, Damian, Sturgeon, Kate, Finn, Adam, Rodriguez-Ruiz, Juan Pablo, Malhotra-Kumar, Surbhi et al (show 9 more authors) , Powell, Colin, Faust, Saul N, Alcock, Anastasia E, Hall, Dani, Robinson, Gisela, Hawcutt, Daniel B ORCID: 0000-0002-8120-6507, Lyttle, Mark D, Gibb, Diana M and Sharland, Mike (2021) Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia The CAP-IT Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 326 (17). pp. 1713-1724.

Collapse authors list.
Tebano, Gianpiero, Li, Grace, Beovic, Bojana, Bielicki, Julia, Brink, Adrian, Enani, Mushira A, Godman, Brian ORCID: 0000-0001-6539-6972, Hinrichsen, Sylvia Lemos, Kibuule, Dan, Gabriel, Levy-Hara et al (show 6 more authors) , Oduyebo, Oyinlola, Sharland, Mike, Singh, Sanjeev, Wertheim, Heiman FL, Nathwani, Dilip and Pulcini, Celine (2019) Essential and forgotten antibiotics: An inventory in low- and middle-income countries. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 54 (3). pp. 273-282.

Collapse authors list.
Darlow, Christopher A ORCID: 0000-0002-5400-3413, Farrington, Nicola, Johnson, Adam, McEntee, Laura, Unsworth, Jennifer, Jimenez-Valverde, Ana, Kolamunnage-Dona, Ruwanthi ORCID: 0000-0003-3886-6208, Da Costa, Renata MA, Ellis, Sally, Franceschi, Francois et al (show 5 more authors) , Sharland, Mike, Neely, Michael, Piddock, Laura JV, Das, Shampa ORCID: 0000-0002-2540-4816 and Hope, William ORCID: 0000-0001-6187-878X (2022) Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77 (5). pp. 1334-1343.

Collapse authors list.
Barker, Charlotte IS, Kipper, Karin, Lonsdale, Dagan O, Wright, Kirstie, Thompson, Georgina, Kim, Min, Turner, Mark A ORCID: 0000-0002-5299-8656, Johnston, Atholl, Sharland, Mike, Standing, Joseph F et al (show 1 more authors) and NAPPA, Study Consortium (2023) The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 78 (9). pp. 2148-2161.

Darlow, Christopher A ORCID: 0000-0002-5400-3413, da Costa, Renata MA, Ellis, Sally, Franceschi, Francois, Sharland, Mike, Piddock, Laura, Das, Shampa ORCID: 0000-0002-2540-4816 and Hope, William ORCID: 0000-0001-6187-878X (2021) Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria. PEDIATRIC DRUGS, 23 (5). pp. 465-484.

Li, Grace, Standing, Joseph F, Bielicki, Julia, Hope, William ORCID: 0000-0001-6187-878X, van den Anker, John, Heath, Paul T and Sharland, Mike (2017) The Potential Role of Fosfomycin in Neonatal Sepsis Caused by Multidrug-Resistant Bacteria. DRUGS, 77 (9). pp. 941-950.

Hill, Louise F, Turner, Mark A ORCID: 0000-0002-5299-8656, Lutsar, Irja, Heath, Paul T, Hardy, Pollyanna, Linsell, Louise, Jacqz-Aigrain, Evelyne, Roilides, Emmanuel and Sharland, Mike (2020) An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial. TRIALS, 21 (1). 329-.